Theophylline Structural Formula (Image 01)
Theophylline
Product Images NDC 29033-002
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 29033-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nostrum Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Theophylline (anhydrous) Extended-release Tablets 400 mg Bottle Label (Image 02)
Theophylline (anhydrous) Extended-release Tablets 600 mg Bottle Label (Image 03)
This is a prescription drug containing 600mg of Theophylline (Anhydrous) in extended-release tablet form. Dosage information is available through accompanying prescribing information. It should be stored in a tight, light-resistant container at a controlled room temperature and kept out of reach of children. This batch of 100 tablets was manufactured by Nostrum Laboratories and has an expiration date of 07/2022.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
